These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2617369)

  • 1. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T
    Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.
    Tanaka Y; Saito K; Suzuki H; Eto S; Yamashita U
    J Immunol; 1989 Sep; 143(5):1584-90. PubMed ID: 2527267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
    Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D
    Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.
    Kitani A; Hara M; Hirose T; Norioka K; Harigai M; Hirose W; Suzuki K; Kawakami M; Kawagoe M; Nakamura H
    Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
    Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
    Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
    Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
    J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
    Funauchi M; Sugishima H; Minoda M; Horiuchi A
    J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous production of B cell growth factors by SLE lymphocytes.
    Pelton BK; Denman AM
    Clin Exp Immunol; 1987 Jan; 67(1):159-66. PubMed ID: 3497742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
    Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
    J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y; Sakane T; Tsunematsu T
    J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell differentiation factor production in systemic lupus erythematosus.
    Warrington RJ
    J Rheumatol; 1988 Jan; 15(1):54-8. PubMed ID: 3258385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of an IL-3-producing suppressor T cell resistant to cyclosporin A in the peripheral blood of patients with systemic lupus erythematosus.
    Alcocer-Varela ; Vidaller A; Llorente L; Alarcón-Segovia D
    Clin Exp Immunol; 1988 Sep; 73(3):424-9. PubMed ID: 2974765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.